期刊文献+

血友病合并HIV/HCV感染者肝功能异常的相关因素分析 被引量:2

Correlation factor analysis of abnormal liver functions among hemophiliacs co-infected with HIV/HCV
下载PDF
导出
摘要 目的探讨血友病合并艾滋病病毒/丙型肝炎病毒(HIV/HCV)感染者CD4计数和HIV病毒载量,与HIV/HCV重叠感染者肝功能异常的相关性。方法观察了63例血友病合并HIV/HCV感染者,据CD4计数和HIVRNA阳性情况,比较肝功能异常的发生率与细胞免疫、HIVRNA阳性的相关性。结果CD4≤200细胞/mm3者20例中,有肝功能异常者14例,与CD4计数>200细胞/mm3组肝功能异常发生率有统计学差异(P<0.05)。HIVRNA阳性的38例中,有肝功能异常者22例,与HIVRNA阴性组肝功能异常发生率有统计学差异(P<0.05)。肝功能异常组的CD4计数较肝功能正常组为低,HIVRNA定量较正常组为高,其差异有统计学意义(P<0.05)。结论CD4计数和HIVRNA阳性情况,可作为血友病合并HIV/HCV感染者肝功能异常的预测因素。 Objective To investigate the relation between CD4 counts, viral loads and abnormal liver function among hemophiliacs co-infected with HIV/HCV. Method Retrospective study was designed to analysis the immunological function,HIVRNA viral loads,prevalence of abnormal liver functions among 63 cases of hemophiliaes co-infected with HIV/ HCV. Results In 20 cases of hemophiliacs with CD4 count below 200,14 had abnormal liver functions. Compared to those with CD4 count above 200, the prevalence of abnormal liver function in cases with CD4 count below 200 had significant statistical difference( P 〈 0.05). In 38 HIV positive cases 22 had abnormal liver functions. Compared to HIV negative cases, the prevalence of abnormal liver function in HIV positive cases had significant statistical difference( P 〈0.05). Compared to the cases with normal liver functions, the CD4 count was lower than in cases with abnormal liver functions, but HIVRNA was higher, and there was significant statistical difference(P〈 0.05). Conclusion CD4 count and positive HIVRNA may be used as predictors of abnormal liver functions in hemophiliacs co-infected with HIV/HCV.
出处 《中国艾滋病性病》 CAS 2006年第5期415-417,共3页 Chinese Journal of Aids & STD
关键词 血友病 艾滋病病毒厂丙型肝炎病毒 共同感染 肝功能异常 相关因素分析 Hemophiliacs HIV/HCV co-infection Liver function Correlation factors analysis
  • 相关文献

参考文献13

  • 1Sherman K,Roustrer S,Chung R,et al.Hepatitis C:prevalence in HIV-infected patients across sectional analysis of the USACTG[J].Antiviral Ther,200,5(Suppl.1):64-65.
  • 2Jhagan H,Thiede H.Sharing ofdrug preparation equipment as a risk factor for hepatitis[J].C Am J Public Health,2001,91:42-46.
  • 3Silva LK,Silva MB,Lopes GB,et al.Prevalence of hepatitis C virus infection and HCV genotypes among hemophiliacs in the State of Bahia,Northeastern Brazil:analysis of serological and virological parameters[J].Rev Soc Bras Med Trop,2005,38(6):496-502.
  • 4Dragoni F,Gentile G,Cartoni C,et al.The role of real-time ultrasonography in predicting esophageal varices in hemophiliacs co-infected with hepatitis C and human immunodeficiency virus[J].Haematologica,2005,90(2):207-213.
  • 5丁培芳,张心声,李钦伟,申法奎,张梅红,宋玮.1992~2000年血友病甲患者HCV、HBV、HIV和梅毒感染情况调查分析[J].血栓与止血学,2002,8(3):115-117. 被引量:11
  • 6周釥民,郭志宏,汤德骥,邵建.4例血友病HIV感染者的追踪观察[J].中国预防医学杂志,2001,2(1):5-7. 被引量:4
  • 7Massimo Puoti,Maurizio Bonacini.Liver Fibrosis Progressioh Is Relatedto CD4Cell Depletion in Patient Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus[J].J Infect Dis,2001,183:134-137.
  • 8Soriano V,Rodriguez-Rosado R,Garcia-Samaniego J.Management of chronic hepatitis C in HIV-infected patients[J].AIDS,1999,13:539-546.
  • 9Gilson RJ,Hawkins AE,Beecham MR,et al.Interactions between HIV and hepatitis B virus in homosexual men:effects on the natural history of infection[J].AIDS,1997,11:597-606.
  • 10Thomas DL,Shih JW,Vlahov D,et al.Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users[J].J Infect Dis,1996,174:690-695.

二级参考文献4

  • 1丁培芳,申法奎,李继红,马京香,刘德春.甲型血友病患者HBsAg和抗-HCV的初步检测[J].中国输血杂志,1996,9(4):209-209. 被引量:5
  • 2曾毅 王必常 汤德骥 等.血友病患者血清中淋巴腺病病毒/人T细胞Ⅲ型病毒抗体检测[J].病毒学报,1986,2:97-99.
  • 3汤德骥 郎亚民 曾毅.浙江省对艾滋病病毒感染者的治疗经验[J].艾滋病简报,1991,12.
  • 4邵建.浙江省对HIV感染者的综合管理及效果评价[J].艾滋病简报,1991,12.

共引文献13

同被引文献13

  • 1Alter M J. Epidemiology of viral hepatitis and HIV co-infection [J]. J Hepatol, 2006,44 ( 1 Suppl ) :S6- 89.
  • 2Sulkowski M S, Mehta S H, Torbenson M S, et al. Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults [J]. AIDS, 2007,21 (16) : 2209-2216.
  • 3Schiavini M, Angeli E, Mainini A, et al. Risk factors for fibrosis progression in HIV/HCV coinfected patients from a retrospective analysis of liver biopsies in 1985-2002 [J]. HIV Med, 2006,7 (5) : 331-337.
  • 4Feikin D R, Feldman C, Schuchat A, et al. Global strategies to prevent bacterial pneumonia in adults with HIV disease [J]. Lancet Infect Dis, 2004,4(7) :445-455.
  • 5Messou E, Anglaret X, Bonard D, et al. The effect of cotrimoxazole coadministrated with antituberculous drugs on serum transaminases in HIV-infected adults from the Ivory Coast [J]. Br J Clin Pharmacol, 2001,52 (5) : 611-612.
  • 6Kress K D. Antiretroviral-associated hepatotoxicity [J]. Curr Infect Dis Rep, 2005,7(2) : 103-107.
  • 7Merchante N, Giron-Gonzalez J A, Gonzalez-Serrano M, et al.Survival and prognostic factors of HIV-infeeted patients with HCV- related end-stage liver disease [J].AIDS, 2006,20 ( 1 ) : 49-57.
  • 8Delladetsima J, Katsarou O, Touloumi G, et al. Significance of immune status, genotype and viral load in the severity of chronic hepatitis C in HIV infected haemophilia patients [J]. Haemophilia, 2002,8 (5) : 668-673.
  • 9[1]HORITA K.Treatment of a patient with hemophilia A and hepatitis C virus-related cirrhosis by living-related liver transplantation from an obligate carrier donor[J].Transplantation,2002,,73(12):1909-1912.
  • 10[2]FRIED MW,PETER J,HOOTS K,et al.Hepatitis C in adults and adolescents with hemophilia:a randomized,controlled trial of interferon alfa-2b and ribavirin[J].Hepatology,2002,,36(4,):967-972.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部